Skip to main content

Table 3 Characteristics of drugs traditionally considered to require TDM [92, 93]

From: Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review

No.

Criteria

1

Narrow therapeutic range/index

2

Drug toxicity may lead to hospitalization, irreversible organ damage, and even death

3

No clearly defined clinical parameter that allows dose adjustments

4

Correlation exists between serum concentration and efficacy as well as toxicity

5

Unpredictable relationship between dose and clinical outcome

6

Difficult to predict pharmacokinetics (e.g. non-linear pharmacokinetics)